loadpatents
Patent applications and USPTO patent grants for Giladi; Eliezer.The latest application filed is for "use of adnf polypeptides for treating anxiety and depression".
Patent | Date |
---|---|
Use of ADNF polypeptides for treating anxiety and depression Grant 8,618,043 - Gozes , et al. December 31, 2 | 2013-12-31 |
Use Of Adnf Polypeptides For Treating Anxiety And Depression App 20120015878 - Gozes; Illana ;   et al. | 2012-01-19 |
Orally active peptides that prevent cell damage and death Grant 8,017,578 - Brenneman , et al. September 13, 2 | 2011-09-13 |
Use of ADNF III polypeptides for treating mental diseases and disorders, including schizophrenia Grant 7,960,334 - Gozes , et al. June 14, 2 | 2011-06-14 |
Orally Active Peptides That Prevent Cell Damage And Death App 20080194488 - Gozes; Illana ;   et al. | 2008-08-14 |
Orally active peptides that prevent cell damage and death Grant 7,384,908 - Brenneman , et al. June 10, 2 | 2008-06-10 |
Use of adnf polypeptides for treating anxiety and depression App 20070054847 - Gozes; Illana ;   et al. | 2007-03-08 |
Methods of treating and/or preventing autoimmune diseases App 20040235747 - Gozes, Illana ;   et al. | 2004-11-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.